2017 American Transplant Congress
Is Once-Daily Extended-Release Tacrolimus Better Than Twice-Daily Standard-Release Tacrolimus? A Meta-Analysis of Randomized Controlled Trials.
Tacrolimus is one of the major immunosuppressants commonly used in transplant recipients. Extended-release tacrolimus is expected to have immunosuppressant effects equivalent to standard-release tacrolimus while…2017 American Transplant Congress
The Impact of Early Clinical and Subclinical T Cell Rejection After Kidney Transplantation.
Medicine and Surgery, University of Pittsburgh, Pittsburgh, PA
Purpose: To evaluate the impact of early Clinical(C-TCMR) and Sub-Clinical(SC-TCMR) T Cell Mediated Rejection on short-term allograft histology and function.Methods: We examined adult kidney alone…2017 American Transplant Congress
Obesity Is an Important Factor in Deceased but Not Living Donor Kidney Transplants.
Cardiff Transplant Unit, University Hospital of Wales, Cardiff, United Kingdom
Introduction There is an increasing obesity among potential kidney transplant recipients. We had in the past shown that obesity did increase the wound infection rate,…2017 American Transplant Congress
Strategies to Promote Pediatric Kidney Transplant Program in China – A Coming Opportunity with Development of Pediatric Deceased Donation.
Introduction This article demonstrates the opportunity and challenges of current pediatric kidney transplant program in China, based on the analysis study of the national registry…2017 American Transplant Congress
Impairment of Glucose Tolerance After Pediatric Kidney Transplant Is Associated with Worse Systemic Insulin Sensitivity Rather Than Fall in Insulin Secretion.
Renal and Genitourinary Surgery, Hokkaido University, Sapporo, Hokkaido, Japan
Introduction and Objective: Tacrolimus and steroid are considered to affect insulin secretion and insulin sensitivity, respectively, resulting in worse glucose tolerance after pediatric kidney transplant…2017 American Transplant Congress
The Impact of De Novo Post-Transplant Diabetes on Hepatic Steatosis and Liver Transplant Outcomes.
Introduction: As the prevalence of diabetes (DM) increases in the general population, it is also increasing in the transplant (Tx) population. Post-transplant diabetes (PTDM) has…2017 American Transplant Congress
Limited Impact of Pre-Existing Donor Specific HLA Antibodies on Long Term Survival After First Adult Liver Transplantation.
Donor specific antibodies (DSA) are known to play a pivotal role in long term kidney allograft survival. Their importance in liver transplanted patients (LTX) is…2017 American Transplant Congress
Donor and Recipient Factors Important in Determining the Estimated GFR Difference Between Living Donor and Recipient Pairs Six Months After Transplant.
Medicine, Division of Nephrology, Sacred Heart Hospital, Pensacola, FL
Analysis of the relationship between living donor and recipient estimated GFR (eGFR) six months after transplant revealed that in the first half of the last…2017 American Transplant Congress
How Potential Living Kidney Donors (LKDs) View ESRD Risk: A Multi-Center Study.
1Yale U, New Haven; 2U Pennsylvania, Philadelphia; 3Northwestern U, Chicago
PurposeTo determine how kidney donors view ESRD risk at initial donor evaluation.MethodsWe conducted a longitudinal, prospective study of LKDs at three centers and report results…2017 American Transplant Congress
Impact of Type of Kidney (Living vs. Deceased) on Urinary Podocyte Excretion Rate in Renal Allografts.
Aim: Long term allograft survival has not improved.Surveillance biopsy studies have demonstrated that chronic microcirculatory injury and progressive glomerulosclerosis are the most common histological finding…
- « Previous Page
- 1
- …
- 59
- 60
- 61
- 62
- 63
- …
- 181
- Next Page »